search
Back to results

An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence

Primary Purpose

Urinary Incontinence

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
bion
Sponsored by
Boston Scientific Corporation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Urinary Incontinence focused on measuring Incontinence, Refractory, Urinary, Urge, Stimulation, Nerve, Microstimulator, Neuromodulation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Key Inclusion Criteria: Age 18 years and above. Diagnosed with urinary urge incontinence. Have no reported history of urethral obstruction/stricture, bladder calculi or bladder tumor. Have normal upper urinary tract function. Be capable of giving informed consent. Be capable and willing to follow all study related procedures. Key Exclusion Criteria: Have any active implantable device regardless of whether stimulation status is ON or OFF. Are pregnant as confirmed by a urine pregnancy test or plan to become pregnant during the following 12 months period. Less than one year post partum and/or are breast-feeding. Have any passive implant that contains metal or electrically conductive materials. Have conditions requiring Magnetic Resonance Imaging (MRI) evaluation. Have conditions requiring diathermy procedures. Have an inability to operate the bion Remote Control and bion Recharging System either by self or caregiver. Have diabetes with peripheral nerve involvement or have severe uncontrolled diabetes. Have history of coagulopathy or bleeding disorder. Have a history of pelvic pain as primary diagnosis. Have anatomical restrictions such that the study device placement is not possible. Are currently participating or have participated within the past 30 days in any clinical investigation involving or impacting urinary or renal function. Have a life expectancy of less than 1 year. Cannot independently comprehend and complete the QoL questionnaires.

Sites / Locations

  • Arizona Health Sciences Center (University of Arizona)
  • The Department of Urology, Stanford University Medical Center
  • Milestone Medical Research
  • Bladder Control Center of Norwalk
  • Walter Reed Army Medical Center, Division of Pelvic Medicine and Reconstructive Surgery
  • William Beaumont Hospital
  • Cornerstone Medical Specialty Center
  • The Pelvic and Sexual Health Institute (affiliated with Graduate Hospital)
  • Dallas Center for Pelvic Medicine
  • Baylor College of Medicine
  • Sound Urological Associates

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

1

2

Arm Description

Stimulation On from Initial Activation up to the 12 month post-activation. Stimulation Off from 12 months post-activation until 45 days after the 12 month visit. Stimulation On from 45 days post 12 month visit and on.

No Stimulation until 45 days post-implant. Stimulation On from 45 days post-implant and on.

Outcomes

Primary Outcome Measures

Number of Leaks Per Day
Freedom From Major Complications

Secondary Outcome Measures

Full Information

First Posted
April 1, 2004
Last Updated
October 25, 2013
Sponsor
Boston Scientific Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT00080470
Brief Title
An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence
Official Title
Battery Powered Bion Clinical Investigation: An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence
Study Type
Interventional

2. Study Status

Record Verification Date
October 2013
Overall Recruitment Status
Completed
Study Start Date
June 2003 (undefined)
Primary Completion Date
July 2008 (Actual)
Study Completion Date
December 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Boston Scientific Corporation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This clinical trial is being conducted to investigate the safety and effectiveness of a new device designed to treat urinary urge incontinence in those patients who have tried and failed two or more conservative therapies.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Incontinence
Keywords
Incontinence, Refractory, Urinary, Urge, Stimulation, Nerve, Microstimulator, Neuromodulation

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
148 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
Stimulation On from Initial Activation up to the 12 month post-activation. Stimulation Off from 12 months post-activation until 45 days after the 12 month visit. Stimulation On from 45 days post 12 month visit and on.
Arm Title
2
Arm Type
Sham Comparator
Arm Description
No Stimulation until 45 days post-implant. Stimulation On from 45 days post-implant and on.
Intervention Type
Device
Intervention Name(s)
bion
Intervention Description
battery powered microstimulator
Primary Outcome Measure Information:
Title
Number of Leaks Per Day
Time Frame
12 months
Title
Freedom From Major Complications
Time Frame
5 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Key Inclusion Criteria: Age 18 years and above. Diagnosed with urinary urge incontinence. Have no reported history of urethral obstruction/stricture, bladder calculi or bladder tumor. Have normal upper urinary tract function. Be capable of giving informed consent. Be capable and willing to follow all study related procedures. Key Exclusion Criteria: Have any active implantable device regardless of whether stimulation status is ON or OFF. Are pregnant as confirmed by a urine pregnancy test or plan to become pregnant during the following 12 months period. Less than one year post partum and/or are breast-feeding. Have any passive implant that contains metal or electrically conductive materials. Have conditions requiring Magnetic Resonance Imaging (MRI) evaluation. Have conditions requiring diathermy procedures. Have an inability to operate the bion Remote Control and bion Recharging System either by self or caregiver. Have diabetes with peripheral nerve involvement or have severe uncontrolled diabetes. Have history of coagulopathy or bleeding disorder. Have a history of pelvic pain as primary diagnosis. Have anatomical restrictions such that the study device placement is not possible. Are currently participating or have participated within the past 30 days in any clinical investigation involving or impacting urinary or renal function. Have a life expectancy of less than 1 year. Cannot independently comprehend and complete the QoL questionnaires.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tamara Baynham, PhD
Organizational Affiliation
Boston Scientific, Neuromodulation
Official's Role
Study Director
Facility Information:
Facility Name
Arizona Health Sciences Center (University of Arizona)
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85724
Country
United States
Facility Name
The Department of Urology, Stanford University Medical Center
City
Stanford
State/Province
California
ZIP/Postal Code
94305-5118
Country
United States
Facility Name
Milestone Medical Research
City
Englewood
State/Province
Colorado
ZIP/Postal Code
80112
Country
United States
Facility Name
Bladder Control Center of Norwalk
City
Norwalk
State/Province
Connecticut
ZIP/Postal Code
06850
Country
United States
Facility Name
Walter Reed Army Medical Center, Division of Pelvic Medicine and Reconstructive Surgery
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20307-5001
Country
United States
Facility Name
William Beaumont Hospital
City
Royal Oak
State/Province
Michigan
ZIP/Postal Code
48073
Country
United States
Facility Name
Cornerstone Medical Specialty Center
City
Woodbury
State/Province
Minnesota
ZIP/Postal Code
55125
Country
United States
Facility Name
The Pelvic and Sexual Health Institute (affiliated with Graduate Hospital)
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19146
Country
United States
Facility Name
Dallas Center for Pelvic Medicine
City
Dallas
State/Province
Texas
ZIP/Postal Code
75231
Country
United States
Facility Name
Baylor College of Medicine
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Facility Name
Sound Urological Associates
City
Edmonds
State/Province
Washington
ZIP/Postal Code
98026
Country
United States

12. IPD Sharing Statement

Learn more about this trial

An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence

We'll reach out to this number within 24 hrs